Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2011: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2010: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2009: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Research Abstract |
In clear cell renal cell carcinoma(CCRCC) patients, MTHFR and RASSF1A genotypes and haplotypes might be useful as prognostic factors. Furthermore, these findings might contribute to the understanding of the mechanisms underlying CCRCC progression. We have found copy number variations that are potentially involved in the risk of CCRCC development.
|